Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    David Vera

    TitleProfessor In Residence
    SchoolUniversity of California, San Diego
    DepartmentRadiology
    Address9500 Gilman Drive #0819
    CA La Jolla 92093
    Phone858-822-2574
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California, DavisPh.D. degree in Biophysics
      University of California, San FranciscoB.S. degree in BiologySchool of Medicine

      Collapse Research 
      Collapse Research Activities and Funding
      MR Solutions Benchtop Cryogen Free Superconducting 1.5T/3.0T Rodent MR Scanner
      NIH S10OD018225Apr 17, 2015 - Apr 16, 2016
      Role: Co-Principal Investigator
      In Vivo Cellular and Molecular Imaging Centers (ICMICs)
      NIH/NCI P50CA128346Sep 23, 2008 - Aug 31, 2014
      Role: Principal Investigator
      In Vivo Cellular and Molecular Imaging Centers (ICMICs)
      NIH/NCI P20CA134224Sep 28, 2007 - Aug 31, 2009
      Role: Principal Investigator
      Workshop on Molecular Imaging Agents
      NIH/NCI R13CA126365Apr 1, 2007 - Mar 31, 2008
      Role: Principal Investigator
      Size-Dependent Uptake of Tc(I)-Labeled RGD Analogs
      NIH/NCI R41CA112797Jan 12, 2005 - Dec 31, 2006
      Role: Principal Investigator
      Workshop on Receptor-Binding Radiotracers 2003
      NIH/NCI R13CA101304Feb 10, 2003 - Jan 31, 2004
      Role: Principal Investigator
      BLOOD POOL CONTRAST AGENTS FOR CT AND MRI
      NIH/NIBIB R01EB002111Apr 1, 2000 - Mar 31, 2005
      Role: Principal Investigator
      BLOOD POOL CONTRAST AGENTS FOR CT AND MRI
      NIH/NCI R01CA082335Apr 1, 2000 - Mar 31, 2004
      Role: Principal Investigator
      RECEPTOR BINDING RADIOTRACER FOR SENTINEL NODE IMAGING
      NIH/NCI R01CA072751Feb 1, 1997 - Jan 31, 2002
      Role: Principal Investigator
      RECEPTOR-BASED RADIOTRACERS FOR CARDIOVASCULAR IMAGING
      NIH/NHLBI R01HL035346Dec 1, 1985 - Nov 30, 1986
      Role: Principal Investigator
      VALIDATION OF A KINETIC MODEL FOR RECEPTOR IMAGING
      NIH/NIDDK R01DK034768Dec 1, 1984 - Mar 31, 1996
      Role: Principal Investigator
      VALIDATION OF A KINETIC MODEL FOR RECEPTOR IMAGING
      NIH/NIADDK R23AM034768Dec 1, 1984 - Nov 30, 1985
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Lee HJ, Barback CV, Hoh CK, Qin Z, Kader K, Hall DJ, Vera D, Kane CJ. Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes. J Nucl Med. 2017 Apr; 58(4):547-553. PMID: 28153955.
        View in: PubMed
      2. Mendez N, Liberman A, Corbeil J, Barback C, Viveros R, Wang J, Wang-Rodriguez J, Blair SL, Mattrey R, Vera D, Trogler W, Kummel AC. Assessment of in vivo systemic toxicity and biodistribution of iron-doped silica nanoshells. Nanomedicine. 2017 Apr; 13(3):933-942. PMID: 27840314.
        View in: PubMed
      3. Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera D. Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. Nucl Med Biol. 2016 Feb; 43(2):179-87. PMID: 26872443.
        View in: PubMed
      4. Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera D, Wallace AM. Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S559-65. PMID: 26275779; PMCID: PMC4686557.
      5. Qin Z, Hoh CK, Hall DJ, Vera D. A tri-modal molecular imaging agent for sentinel lymph node mapping. Nucl Med Biol. 2015 Dec; 42(12):917-22. PMID: 26320812.
        View in: PubMed
      6. Azad AK, Rajaram MV, Metz WL, Cope FO, Blue MS, Vera D, Schlesinger LS. ?-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206). J Immunol. 2015 Sep 01; 195(5):2019-29. PMID: 26202986; PMCID: PMC4543904.
      7. Liss MA, Stroup SP, Qin Z, Hoh CK, Hall DJ, Vera D, Kane CJ. Robotic-assisted fluorescence sentinel lymph node mapping using multimodal image guidance in an animal model. Urology. 2014 Oct; 84(4):982.e9-14. PMID: 25139676; PMCID: PMC4366424.
      8. Baker JL, Pu M, Tokin CA, Hoh CK, Vera D, Messer K, Wallace AM. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients. Ann Surg Oncol. 2015 Jan; 22(1):40-5. PMID: 25069859; PMCID: PMC4273083.
      9. Liss MA, Farshchi-Heydari S, Qin Z, Hickey SA, Hall DJ, Kane CJ, Vera D. Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging. J Nucl Med. 2014 Sep; 55(9):1552-6. PMID: 25024425; PMCID: PMC4350927.
      10. Hosseini A, Baker JL, Tokin CA, Qin Z, Hall DJ, Stupak DG, Hayashi T, Wallace AM, Vera D. Fluorescent-tilmanocept for tumor margin analysis in the mouse model. J Surg Res. 2014 Aug; 190(2):528-34. PMID: 24923630; PMCID: PMC4201840.
      11. Lajtos I, Czernin J, Dahlbom M, Daver F, Emri M, Farshchi-Heydari S, Forgacs A, Hoh CK, Joszai I, Krizsan AK, Lantos J, Major P, Molnar J, Opposits G, Tron L, Vera D, Balkay L. Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom. Phys Med Biol. 2014 Jun 07; 59(11):2727-46. PMID: 24800813.
        View in: PubMed
      12. Qin Z, Hall DJ, Liss MA, Hoh CK, Kane CJ, Wallace AM, Vera D. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J Biomed Opt. 2013 Oct; 18(10):101315. PMID: 23958947; PMCID: PMC3745642.
      13. Liberman A, Wu Z, Barback CV, Viveros R, Blair SL, Ellies LG, Vera D, Mattrey RF, Kummel AC, Trogler WC. Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells. ACS Nano. 2013 Jul 23; 7(7):6367-77. PMID: 23802554; PMCID: PMC3777724.
      14. Haubner R, Vera D, Farshchi-Heydari S, Helbok A, Rangger C, Putzer D, Virgolini IJ. Development of 68Ga-labelled DTPA galactosyl human serum albumin for liver function imaging. Eur J Nucl Med Mol Imaging. 2013 Aug; 40(8):1245-55. PMID: 23579865.
        View in: PubMed
      15. Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera D. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials. Ann Surg Oncol. 2013 Aug; 20(8):2590-9. PMID: 23504141; PMCID: PMC3705144.
      16. Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane CJ, Wallace AM, Vera D. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012 Oct; 265(1):186-93. PMID: 22753678; PMCID: PMC3447170.
      17. Tokin CA, Cope FO, Metz WL, Blue MS, Potter BM, Abbruzzese BC, Hartman RD, Joy MT, King DW, Christman LA, Vera D, Wallace AM. The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ??mTc-labeled nanocolloid human serum albumin standard of care. Clin Exp Metastasis. 2012 Oct; 29(7):681-6. PMID: 22729510.
        View in: PubMed
      18. Stroup SP, Kane CJ, Farchshchi-Heydari S, James CM, Davis CH, Wallace AM, Hoh CK, Vera D. Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model. Clin Exp Metastasis. 2012 Oct; 29(7):673-80. PMID: 22714690.
        View in: PubMed
      19. Ting R, Aguilera TA, Crisp JL, Hall DJ, Eckelman WC, Vera D, Tsien RY. Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjug Chem. 2010 Oct 20; 21(10):1811-9. PMID: 20873712; PMCID: PMC2957852.
      20. Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera D. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. Nucl Med Biol. 2009 Aug; 36(6):687-92. PMID: 19647175; PMCID: PMC4201841.
      21. Wang X, Zhao G, Van S, Jiang N, Yu L, Vera D, Howell SB. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts. Cancer Chemother Pharmacol. 2010 Feb; 65(3):515-26. PMID: 19593566; PMCID: PMC2797414.
      22. Wu W, Kitamura S, Truong DM, Rieg T, Vallon V, Sakurai H, Bush KT, Vera D, Ross RS, Nigam SK. Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function. Am J Physiol Renal Physiol. 2009 Jul; 297(1):F210-7. PMID: 19439520; PMCID: PMC2711709.
      23. Eckelman WC, Vera D. After bench to bedside: the impact of disease progression, commercial opportunities and available instrumentation on clinical outcome. Nucl Med Biol. 2007 Oct; 34(7):727-8. PMID: 17921023.
        View in: PubMed
      24. Wallace AM, Hoh CK, Darrah DD, Schulteis G, Vera D. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. Nucl Med Biol. 2007 Oct; 34(7):849-53. PMID: 17921035; PMCID: PMC4189800.
      25. Obrzut S, Pham RH, Vera D, Badran K, Hoha CK. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET. Nucl Med Commun. 2007 Jan; 28(1):7-13. PMID: 17159543.
        View in: PubMed
      26. Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera D. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol. 2007 Feb; 14(2):913-21. PMID: 17146742.
        View in: PubMed
      27. Schöder H, Glass EC, Pecking AP, Harness JK, Wallace AM, Hirnle P, Alberini JL, Vilain D, Larson SM, Hoh CK, Vera D. Molecular targeting of the lymphovascular system for imaging and therapy. Cancer Metastasis Rev. 2006 Jun; 25(2):185-201. PMID: 16770532.
        View in: PubMed
      28. Salem CE, Hoh CK, Wallace AM, Vera D. A preclinical study of prostate sentinel lymph node mapping with [99mTC]diethylenetetramine pentaacetic acid-mannosyl-dextran. J Urol. 2006 Feb; 175(2):744-8. PMID: 16407043.
        View in: PubMed
      29. Wallace AM, Ellner SJ, Méndez J, Hoh CK, Salem CE, Bosch CM, Orahood RC, Vera D. Minimally invasive sentinel lymph node mapping of the pig colon with Lymphoseek. Surgery. 2006 Feb; 139(2):217-23. PMID: 16455331.
        View in: PubMed
      30. Eckelman WC, Rohatagi S, Krohn KA, Vera D. Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic? Nucl Med Biol. 2005 Oct; 32(7):657-62. PMID: 16243639.
        View in: PubMed
      31. Vera D, Hall DJ, Hoh CK, Gallant P, McIntosh LM, Mattrey RF. Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry. Nucl Med Biol. 2005 Oct; 32(7):687-93. PMID: 16243643.
        View in: PubMed
      32. Scheibe PO, Vera D, Eckelman WC. What is to be gained by imaging the same animal before and after treatment? Nucl Med Biol. 2005 Oct; 32(7):727-32. PMID: 16243648.
        View in: PubMed
      33. Wallace AM, Comstock C, Hoh CK, Vera D. Breast imaging: a surgeon's prospective. Nucl Med Biol. 2005 Oct; 32(7):781-92. PMID: 16243654.
        View in: PubMed
      34. Sirlin CB, Vera D, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad Radiol. 2004 Dec; 11(12):1361-9. PMID: 15596374.
        View in: PubMed
      35. Ellner SJ, Méndez J, Vera D, Hoh CK, Ashburn WL, Wallace AM. Sentinel lymph node mapping of the colon and stomach using lymphoseek in a pig model. Ann Surg Oncol. 2004 Jul; 11(7):674-81. PMID: 15231522.
        View in: PubMed
      36. Eckelman WC, Vera D. From bench to bedside. Nucl Med Biol. 2003 Nov; 30(8):793-4. PMID: 14698781.
        View in: PubMed
      37. Ellner SJ, Hoh CK, Vera D, Darrah DD, Schulteis G, Wallace AM. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping. Nucl Med Biol. 2003 Nov; 30(8):805-10. PMID: 14698783.
        View in: PubMed
      38. Kokudo N, Vera D, Makuuchi M. Clinical application of TcGSA. Nucl Med Biol. 2003 Nov; 30(8):845-9. PMID: 14698788.
        View in: PubMed
      39. Méndez J, Wallace AM, Hoh CK, Vera D. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs. J Nucl Med. 2003 Oct; 44(10):1677-81. PMID: 14530486.
        View in: PubMed
      40. Hoh CK, Wallace AM, Vera D. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran . Nucl Med Biol. 2003 Jul; 30(5):457-64. PMID: 12831982.
        View in: PubMed
      41. Wallace AM, Hoh CK, Vera D, Darrah DD, Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol. 2003 Jun; 10(5):531-8. PMID: 12794019.
        View in: PubMed
      42. Vera D, Mattrey RF. A molecular CT blood pool contrast agent. Acad Radiol. 2002 Jul; 9(7):784-92. PMID: 12139092.
        View in: PubMed
      43. Vera D, Wallace AM, Hoh CK. [(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection. Nucl Med Biol. 2001 Jul; 28(5):493-8. PMID: 11516693.
        View in: PubMed
      David's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _